IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues

Garland, Suzanne M.; Iftner, Thomas; Cuschieri, Kate; Kaufmann, Andreas M.; Arbyn, Marc; de Sanjose, Silvia; Poljak, Mario; Dillner, Joakim; Unger, Elizabeth R.

dc.contributor.author	Iftner, Thomas
dc.date.accessioned	2023-11-10T10:54:45Z
dc.date.available	2023-11-10T10:54:45Z
dc.date.issued	2023
dc.identifier.issn	1386-6532
dc.identifier.uri	http://hdl.handle.net/10900/147462
dc.language.iso	en	en
dc.publisher	Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.jcv.2022.105349
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230619000000_01763
utue.personen.roh	Garland, Suzanne M.
utue.personen.roh	Iftner, Thomas
utue.personen.roh	Cuschieri, Kate
utue.personen.roh	Kaufmann, Andreas M.
utue.personen.roh	Arbyn, Marc
utue.personen.roh	de Sanjose, Silvia
utue.personen.roh	Poljak, Mario
utue.personen.roh	Dillner, Joakim
utue.personen.roh	Unger, Elizabeth R.
dcterms.isPartOf.ZSTitelID	Journal of Clinical Virology	de_DE
dcterms.isPartOf.ZS-Issue	Article 105349	de_DE
dcterms.isPartOf.ZS-Volume	159	de_DE
utue.fakultaet	04 Medizinische Fakultät